Home » Topics » BioWorld Science

BioWorld Science
RSS

PLC Systems can halt randomization to medical therapy in TMR trial

Sep. 20, 1996

AMI and magnesium supplementation

Sep. 20, 1996

Use of bisaramil in oxidative stress-related conditions

Sep. 20, 1996

Valaciclovir for restenosis

Sep. 20, 1996

Renin inhibitors in cardiovascular disease

Sep. 20, 1996

Zambon's ACE/NEP inhibitors for cardiovascular indications

Sep. 20, 1996

Sepracor updates progress on (R)-albuterol

Sep. 20, 1996

Customized asthma treatment introduced in the U.S.

Sep. 20, 1996

LTD4 antagonist selected for further evaluation by Menarini

Sep. 20, 1996

Schering AG investigates LTB4 inhibitors

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026